MDWD · MediWound Ltd.
$13.77
-0.03 (-0.22%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$178.68M
Shares
12.91M
Volume · Sep 30
83.89K
Avg daily vol (3M)
85.58K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$13.77
Open$13.80
Day$13.59–13.98
52W close$12.61–19.69
Avg vol 30d105K
Short int1.8M · 14.0% float · 14.4d
Short vol66%
Last earningsAug 13, 2026
DataJan 2020–Sep 2026
Up next
Next earnings call
Nov 4, 2026
Est · unconfirmed
· in 5 wks
call held Aug 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+12.7%
Year over year
Operating margin
-149.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+18.9%
Year over year · more shares
Price change (1Y)
-23.2%
Trailing year
Short interest
14.0%
Latest settlement · 14.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Moderate
Market backdrop
VIX 16.3 · calm
Equity put/call 0.53
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−13%
below
Price vs 50-day avg
+1%
above
RSI (14)
53
neutral
MACD trend
Positive
52-week position
16%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+9%
trailing
6-month return
−23%
trailing
YTD return
−25%
this year
Relative strength
−35%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $14 › 200d $16 — 200d above 50d
Institutional flow
Accumulating
+1% holders QoQ · +14 funds added
Insider flow
Distributing
Net -$75.4K over 90 days · 67% sells
Short interest
Rising
14.05% of float · ▲ +11.4% MoM · 14.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
78 holders — near 3-yr high, broad support
Squeeze score
85
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
40%
annualized · 1-yr
Max drawdown
−36%
past year
ATR
3.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jun 30, 2026
Full year 2026 revenue
· full year 2026
Initiated
$24M – $26M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−13%
Bearish
Price vs 50-day avg
+1%
Bullish
RSI (14)
53
Neutral
MACD trend
Positive
Bullish
52-week position
16%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $14 › 200d $16 — 200d above 50d
Institutional flow
Accumulating
+1% holders QoQ · +14 funds added
Insider flow
Distributing
Net -$75.4K over 90 days · 67% sells
Short interest
Rising
14.05% of float · ▲ +11.4% MoM · 14.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
78 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $13
Now $14 · 16%
Range high $20
vs 200-day avg -13%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MDWD
this stock
MediWound Ltd.
|
$178.68M | -25.4% | — | — | 14.0% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.37B | +15.3% | +46.2% | 30.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.13B | -1.8% | +20.8% | 19.5 | 2.5% |
|
MRNA
Moderna, Inc.
|
$79.40B | +553.0% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$61.25B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MDWD | +0.9% | +9.1% | -22.5% | +9.2% | -25.4% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | +1.6% | +9.0% | -34.7% | +9.8% | -37.3% |